Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs).
暂无分享,去创建一个
David M. Shackleford | Christopher J Burns | Susan A Charman | J. Palmer | T. Nero | A. Wilks | H. Treutlein | S. Charman | E. Fantino | Michelle Farrugia | Michelle L. Styles | J. Zeng | Herbert Treutlein | X. Bu | David M Shackleford | James T Palmer | Tracy L Nero | C. Burns | Stephen Su | Jun Zeng | Andrew F Wilks | David G Bourke | Laura Andrau | Xianyong Bu | Andrew C Donohue | Emmanuelle Fantino | Michelle Farrugia | John T Feutrill | Max Joffe | Marcel R Kling | Margarita Kurek | Thao Nguyen | Ian Phillips | Harrison Sikanyika | Michelle Styles | Stephen Su | I. Phillips | Max Joffe | Harrison Sikanyika | J. Feutrill | T. Nguyen | M. Kurek | M. Kling | A. Donohue | Laura Andrau | D. G. Bourke
[1] A. Pardanani. JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials , 2008, Leukemia.
[2] A. Tefferi,et al. CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients , 2009, Leukemia.
[3] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport , 1996 .
[4] J. Rossjohn,et al. The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor. , 2006, Blood.
[5] Norio Miyaura,et al. Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds , 1995 .
[6] S. Buchwald,et al. Simple, efficient catalyst system for the palladium-catalyzed amination of aryl chlorides, bromides, and triflates. , 2000, The Journal of organic chemistry.
[7] Tim Morris,et al. Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.
[8] A. Tefferi. JAK and MPL mutations in myeloid malignancies , 2008, Leukemia & lymphoma.
[9] C. Schindler,et al. Series Introduction: JAK-STAT signaling in human disease , 2002 .
[10] R. Berger,et al. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. , 2000, Blood.
[11] Kristina Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .
[12] S. Rane,et al. Janus kinases: components of multiple signaling pathways , 2000, Oncogene.
[13] M. Aringer,et al. Janus kinases and their role in growth and disease. , 1999, Life sciences.
[14] A. Gilbert,et al. Expedient parallel synthesis of 2-amino-4-heteroarylpyrimidines. , 2005, Organic letters.